119 related articles for article (PubMed ID: 11849662)
1. Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians.
Rizzo MR; Ragno E; Barbieri M; De Lucia D; Manzella D; Tagliamonte MR; Colaizzo D; Margaglione M; Paolisso G
Atherosclerosis; 2002 Feb; 160(2):385-90. PubMed ID: 11849662
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance, plasma PAI-1 levels and PAI-1 gene polymorphism in healthy centenarians.
Barbieri M; Rizzo MR; Ragno E; Grella R; Manzella D; Carbonella M; Saccomanno F; Paolisso G
J Endocrinol Invest; 2002; 25(10 Suppl):110-2. PubMed ID: 12508941
[No Abstract] [Full Text] [Related]
3. Effects of gliclazide on platelet aggregation and the plasminogen activator inhibitor type 1 level in patients with type 2 diabetes mellitus.
Konya H; Hasegawa Y; Hamaguchi T; Satani K; Umehara A; Katsuno T; Ishikawa T; Miuchi M; Kohri K; Suehiro A; Kakishita E; Miyagawa J; Namba M
Metabolism; 2010 Sep; 59(9):1294-9. PubMed ID: 20070990
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
[TBL] [Abstract][Full Text] [Related]
5. Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue.
van Harmelen V; Wahrenberg H; Eriksson P; Arner P
Thromb Haemost; 2000 Feb; 83(2):304-8. PubMed ID: 10739390
[TBL] [Abstract][Full Text] [Related]
6. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
Glueck CJ; Sieve L; Zhu B; Wang P
Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
[TBL] [Abstract][Full Text] [Related]
8. Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort.
Henry M; Tregouët DA; Alessi MC; Aillaud MF; Visvikis S; Siest G; Tiret L; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):84-91. PubMed ID: 9445260
[TBL] [Abstract][Full Text] [Related]
9. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.
Kinik ST; Ozbek N; Yuce M; Yazici AC; Verdi H; Ataç FB
Thromb Haemost; 2008 Feb; 99(2):352-6. PubMed ID: 18278185
[TBL] [Abstract][Full Text] [Related]
10. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
[TBL] [Abstract][Full Text] [Related]
11. Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.
Panahloo A; Mohamed-Ali V; Lane A; Green F; Humphries SE; Yudkin JS
Diabetes; 1995 Jan; 44(1):37-42. PubMed ID: 7813812
[TBL] [Abstract][Full Text] [Related]
12. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
Kinik ST; Ataç FB; Verdi H; Cetintaş S; Sahin FI; Ozbek N
Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
[TBL] [Abstract][Full Text] [Related]
13. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension.
Toft I; Bønaa KH; Ingebretsen OC; Nordøy A; Birkeland KI; Jenssen T
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):553-9. PubMed ID: 9102176
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.
Sogutlu Sari E; Yazici A; Eser B; Erol MK; Kilic A; Ermis SS; Koytak A; Akşit H; Yakut T
Cutan Ocul Toxicol; 2014 Dec; 33(4):270-4. PubMed ID: 24446892
[TBL] [Abstract][Full Text] [Related]
16. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
Matsubara Y; Murata M; Isshiki I; Watanabe R; Zama T; Watanabe G; Watanabe K; Ikeda Y
Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
[TBL] [Abstract][Full Text] [Related]
17. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.
Sartori MT; Vettor R; De Pergola G; De Mitrio V; Saggiorato G; Della Mea P; Patrassi GM; Lombardi AM; Fabris R; Girolami A
Thromb Haemost; 2001 Nov; 86(5):1161-9. PubMed ID: 11816701
[TBL] [Abstract][Full Text] [Related]
18. Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe burns.
Aoki K; Aikawa N; Sekine K; Yamazaki M; Mimura T; Urano T; Takada A
Burns; 2001 Sep; 27(6):569-75. PubMed ID: 11525850
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function.
Paolisso G; Ammendola S; Del Buono A; Gambardella A; Riondino M; Tagliamonte MR; Rizzo MR; Carella C; Varricchio M
J Clin Endocrinol Metab; 1997 Jul; 82(7):2204-9. PubMed ID: 9215295
[TBL] [Abstract][Full Text] [Related]
20. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Gürlek A; Bayraktar M; Kirazli S
Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
